Dr. Li has over twenty years of experiences in finance and biopharmaceutical industry. Currently, He is a Senior Vice President at Eureka Therapeutics, responsible for finance, business and corporate development. Prior to this, Dr. Li was Chief Finance Officer of Ascentage Pharma (2017-18), in charge of finance and business development.  From 2010 to 2017, Dr. Li worked in Strategy and Portfolio Management at Bayer Pharmaceuticals. Between 2002 and 2009, He was equity research analyst at Morgan Stanley and two other Investment banks in New York, covering biotech and biopharmaceutical companies. Han holds a Ph.D. degree in Pharmacology from Boston University School of Medicine and an M.B.A. degree from University of California at Los Angeles.